[Invasive pneumococcal strains isolated from children and adolescents in Salvador]

Cristiana N Nascimento-Carvalho1, Leda S Freitas-Souza, Otávio A Moreno-Carvalho

  • 1Universidade Federal da Bahia, Salvador, BA, 40210-630, Brazil. nascimentocarvalho@hotmail.com

Jornal De Pediatria
|September 25, 2003
PubMed

Insights

This study tracked pneumococcal strains in young patients, finding penicillin resistance in 20% of cases. Notably, all penicillin-resistant strains belonged to serotypes covered by the pneumococcal conjugate vaccine.

Area of Science:

  • Microbiology
  • Epidemiology
  • Pediatric Infectious Diseases

Context:

  • Invasive pneumococcal disease (IPD) remains a significant global health concern, particularly in children.
  • Antimicrobial resistance (AMR) in Streptococcus pneumoniae complicates treatment and public health strategies.
  • Serotype distribution is crucial for evaluating the impact of pneumococcal conjugate vaccines (PCVs).

Purpose:

  • To characterize the antimicrobial resistance patterns and serotype distribution of invasive pneumococcal isolates from pediatric patients.
  • To assess the prevalence of specific antimicrobial resistance mechanisms in different pneumococcal serotypes.
  • To determine the proportion of resistant strains covered by existing pneumococcal vaccination schedules.

Summary:

  • A 57-month surveillance identified 70 invasive pneumococcal strains from patients under 20 years old.
  • Resistance was observed for penicillin (20.0%), trimethoprim-sulfamethoxazole (65.7%), and tetracycline (21.4%), with chloramphenicol and vancomycin showing universal susceptibility.
  • The most common serotypes were 14, 5, 6A, 6B, and 19F. Penicillin resistance was concentrated in serotypes 14, 6B, and 19F.
  • A significant proportion (67.2%) of isolates, including all penicillin-resistant strains, were serotypes included in the heptavalent pneumococcal conjugate vaccine (PCV7).

Impact:

  • Findings highlight the ongoing challenge of antimicrobial resistance in pediatric pneumococcal infections.
  • The study underscores the importance of continued surveillance to monitor AMR trends and inform treatment guidelines.
  • The high coverage of resistant strains by PCV7 suggests vaccine effectiveness against key resistant serotypes but also points to the need for updated vaccines to address emerging resistance patterns.
Abstract